Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis

Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis

Detalles Bibliográficos
Autores principales:	Bettencourt, P, Mueller, J, Nicastri, A, Madhavan, M, Fotso, C, Cantillon, D, Charles, P, Wittenberg, R, Bull, N, Pinpathomrat, N, Waddell, S, Stylianou, E, Hill, A, Ternette, N, McShane, H
Formato:	Conference item
Lenguaje:	English
Publicado:	Wiley 2019

Ejemplares similares

Identification of antigens presented by MHC for vaccines against tuberculosis
por: Bettencourt, P, et al.
Publicado: (2020)

Identification of antigens presented by MHC for vaccines against tuberculosis
por: Bettencourt, P, et al.
Publicado: (2020)

Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
por: Purcell, A, et al.
Publicado: (2019)

Immunopeptidomics special issue
por: Ternette, N, et al.
Publicado: (2018)

Discrimination between human leukocyte antigen class I-bound and co-purified HIV-derived peptides in immunopeptidomics workflows
por: Partridge, T, et al.
Publicado: (2018)

Implications of MHC-restricted immunopeptidome in transplantation
por: Zhuldyz Zhanzak, et al.
Publicado: (2024-07-01)

Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer identifies potential immunotherapy target antigens
por: Ternette, N, et al.
Publicado: (2018)

Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
por: Owen Leddy, et al.
Publicado: (2023-04-01)

Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows
por: Thomas Partridge, et al.
Publicado: (2018-04-01)

Solving an MHC allele–specific bias in the reported immunopeptidome
por: Martin G. Klatt, et al.
Publicado: (2020-10-01)

The yin/yang balance of the MHC-self-immunopeptidome
por: Laura Santambrogio, et al.
Publicado: (2022-11-01)

MS-rescue: a computational pipeline to increase the quality and yield of immunopeptidomics experiments
por: Andreatta, M, et al.
Publicado: (2019)

Identification and selection of novel mycobacterial antigens using immunopeptidomics and immunoinformatics for the development of subunit vaccines against tuberculosis
por: Almujri, SS
Publicado: (2022)

Critical Review of Existing MHC I Immunopeptidome Isolation Methods
por: Alexandr Kuznetsov, et al.
Publicado: (2020-11-01)

Molecular Determinants Regulating the Plasticity of the MHC Class II Immunopeptidome
por: Laura Santambrogio, et al.
Publicado: (2022-05-01)

Identification and evaluation of novel protective antigens for the development of a candidate TB subunit vaccine
por: Stylianou, E, et al.
Publicado: (2018)

A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge
por: Stylianou, E, et al.
Publicado: (2023)

Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues
por: Peter Kubiniok, et al.
Publicado: (2022-02-01)

Escape from the phagosome: the explanation for MHC-I processing of mycobacterial antigens?
por: Melanie eHarriff, et al.
Publicado: (2012-03-01)

The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
por: Etienne Caron, et al.
Publicado: (2011-09-01)

Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1− CD4+ T cells
por: Bull, N, et al.
Publicado: (2018)

Variations in MHC class I antigen presentation and immunopeptidome selection pathways [version 1; peer review: 3 approved]
por: Anita J. Zaitouna, et al.
Publicado: (2020-09-01)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
por: Tanner, R, et al.
Publicado: (2021)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
por: Pinpathomrat, N, et al.
Publicado: (2021)

Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome
por: Saghar Kaabinejadian, et al.
Publicado: (2022-01-01)

Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; Implications for immune recognition
por: Tatyana Sandalova, et al.
Publicado: (2022-08-01)

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome
por: Scott D. Brown, et al.
Publicado: (2019-03-01)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection
por: Betts, G, et al.
Publicado: (2012)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.
por: Gareth Betts, et al.
Publicado: (2012-01-01)

Unlocking the secrets of the immunopeptidome: MHC molecules, ncRNA peptides, and vesicles in immune response
por: Arpita Balakrishnan, et al.
Publicado: (2025-01-01)

Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines
por: Sonali V. Mohan, et al.
Publicado: (2021-03-01)

Obesity Reshapes Visceral Fat-Derived MHC I Associated-Immunopeptidomes and Generates Antigenic Peptides to Drive CD8+ T Cell Responses
por: Xiaoling Chen, et al.
Publicado: (2020-04-01)

A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge
por: Elena Stylianou, et al.
Publicado: (2023-10-01)

Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design
por: Emma C. Jappe, et al.
Publicado: (2020-12-01)

Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients
por: Ongarj, J, et al.
Publicado: (2024)

Editorial: Immunopeptidomic Approaches for the Identification of Tumor (neo)Antigens
por: Jennie R. Lill, et al.
Publicado: (2022-05-01)

Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from <i>Theileria parva</i> Infected Cells
por: Timothy Connelley, et al.
Publicado: (2022-11-01)

Hypoxia inhibits MHC I expression and antigen presentation to escape immune surveillance
por: Estephan, H, et al.
Publicado: (2025)

TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification
por: Naomi Hoenisch Gravel, et al.
Publicado: (2023-11-01)

LTR retroelement expansion of the human cancer transcriptome and immunopeptidome revealed by de novo transcript assembly
por: Attig, J, et al.
Publicado: (2019)